Clinical Trial Detail

NCT ID NCT03230318
Title ARQ 087 in Subjects With FGFR2 Gene Fusion Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements yes
Sponsors ArQule
Indications

intrahepatic cholangiocarcinoma

cholangiocarcinoma

Therapies

Derazantinib

Age Groups: senior adult

Additional content available in CKB BOOST